Business context and reporting period
James Hardie Industries plc filed this Form 20-F annual report for the fiscal year ended 31 March 2022. Although the request metadata refers to “2021 Q4,” the filing reports full-year FY2022 results, with FY2021 as the main comparable period. The company manufactures fiber-cement building products across North America, Asia Pacific and Europe, and fiber-gypsum and cement-bonded boards in Europe. Financial statements are prepared under US GAAP; dollar amounts below are US dollars unless stated otherwise.
Financial performance and liquidity
| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Net sales | $3,614.7 million | $2,908.7 million | +24% |
| Gross margin | 36.3% | 36.2% | +0.1 percentage points |
| Operating income | $682.6 million | $472.8 million | +44% |
| Operating income margin | 18.9% | 16.3% | +2.6 percentage points |
| Net income | $459.1 million | $262.8 million | +75% |
| Diluted EPS | $1.03 | $0.59 | — |
| Adjusted net income (non-GAAP) | $620.7 million | $458.0 million | +36% |
| Adjusted EBIT (non-GAAP) | $815.6 million | $629.0 million | +30% |
| Adjusted diluted EPS (non-GAAP) | $1.39 | $1.03 | — |
Management attributed sales growth to 14% volume growth and 10% price/mix growth. Gross margin was broadly stable despite higher input costs, supported by pricing, higher-value product mix and LEAN manufacturing savings. SG&A rose 18% to $461.2 million, reflecting higher marketing, innovation and talent investment. Reported results included a $131.7 million asbestos-adjustment loss; adjusted measures exclude specified items and should not be treated as US GAAP results.
Segment performance: North America sales were $2,551.3 million (+25%) and operating income was $741.2 million (+27%), with a 29.1% margin. Asia Pacific sales were $574.9 million (+25%) and operating income was $160.8 million (+29%), with a 28.0% margin. Europe Building Products sales were $488.5 million (+19%) and operating income was $62.9 million (+67%), with a 12.9% margin. Europe’s gross margin fell 1.5 percentage points, as higher energy, paper and packaging costs outweighed pricing; reported energy hyperinflation was approximately €9.4 million.
Net cash from operations was $757.2 million, down 4% from $786.9 million, mainly because FY2021 included a $64.8 million CARES Act tax refund. Investing activities used $348.2 million, including $257.8 million of capital expenditure. Financing activities used $449.6 million, including $484.0 million of dividend payments, partly offset by net revolving-credit drawdowns of $40.0 million. Cash and cash equivalents were $125.0 million at year-end, versus $208.5 million.
Gross debt was $886.4 million, versus $868.3 million; balance-sheet long-term debt, net of issuance costs, was $877.3 million. Debt included €400 million of 3.625% notes due 2026, $400 million of 5.000% notes due 2028, and $40 million drawn under the revolving facility. The new $600 million revolving facility matures in December 2026, with two optional one-year extensions; $552.5 million remained available at year-end. Management said existing cash, expected operating cash flow and undrawn facilities should cover expected requirements for the next 12 months. The company targets leverage of 1–2x.
Material changes and unusual items
- Operating income and net income increased substantially, while gross margin was nearly flat amid significant input-cost inflation.
- Capital expenditure increased to $257.8 million from $110.7 million as the company advanced capacity expansions. Management expects $1.6–$1.8 billion of capital expenditure over the following four years.
- Asbestos adjustments were a $131.7 million loss, including a $140.9 million change in estimates, partly offset by foreign-exchange effects. The balance-sheet asbestos liability was $1,143.7 million. Average settlement per claim rose 27% to A$314,000.
- CEO Jack Truong was terminated on 6 January 2022. Harold Wiens became interim CEO, and Michael Hammes took the Executive Chairman role; the company anticipated appointing a new CEO and renewing the Board during FY2023.
- The company paid $309.9 million in a special dividend in April 2021 and $174.1 million in an ordinary interim dividend in December 2021. The filing does not provide a specific FY2023 earnings or EPS forecast.
Outlook, commentary and principal risks
Management expected US residential end-market growth to continue into FY2023, expected the Australian addressable market to increase, and forecast year-on-year sales and operating-margin growth for Europe Building Products. It said the company was on or ahead of plan on its strategic priorities: marketing directly to homeowners, growing existing and new segments (especially Repair and Remodel), and commercializing innovations. Management also cited new capacity, customer integration and product innovation as demand drivers.
Key uncertainties include housing and construction activity, interest rates and affordability, COVID-19 effects, supply-chain disruption, raw-material, freight and energy inflation, competition and pricing pressure, and the execution, timing and cost of planned capacity projects. Europe remains exposed to energy-cost volatility. Currency movements also affect reported results: management estimated that a 10% AUD/USD movement could affect net income by approximately $43.4 million, assuming the unfunded net AFFA liability and no hedging change.
The long-term asbestos funding agreement (AFFA) requires payments to the Asbestos Injuries Compensation Fund (AICF); FY2022 contributions were $248.5 million, and management expected a contribution of approximately A$157.5 million in FY2023. The liability depends on uncertain claims, settlement costs, timing, inflation and exchange rates. Other material contingencies include New Zealand weathertightness litigation: the Cridge appeal was scheduled for August 2022, and the Waitakere trial for May 2023. No reserves were recorded for either matter at 31 March 2022 because loss was assessed as not probable; an adverse outcome could nevertheless be material. The filing also identifies product warranty, environmental and silica-exposure, tax, cybersecurity and privacy risks.
Ernst & Young issued unqualified opinions on the financial statements and internal control over financial reporting; management also concluded controls were effective as of 31 March 2022.
Investor verification checklist
- Reconcile reported net income of $459.1 million with adjusted net income of $620.7 million, focusing on asbestos and tax adjustments and the non-GAAP reconciliations.
- Review the AICF actuarial assumptions, the $1,143.7 million recorded liability, future contributions and sensitivity to claims trends and AUD/USD movements.
- Assess cash conversion and funding needs against the $1.6–$1.8 billion four-year capital program, dividend distributions, debt maturities and the company’s 1–2x leverage target.
- Track delivery, commissioning and utilization of planned capacity expansions, alongside input-cost and energy inflation and their effect on segment margins.
- Monitor the Cridge appeal, Waitakere litigation, product warranty experience, and the outcome of ongoing tax audits.
- Confirm whether expected regional growth and capacity-driven demand developed as management anticipated; the filing provides directional outlook, not quantified earnings guidance.